Medinol ruling hits Guidant
Case may dent value of firm being bought by Boston Scientific
Just a few months after paying $750 million to end its bitter legal fight with former business partner Medinol Ltd., Boston Scientific Corp. has found itself entangled with the Israeli company once again. (Full article: 682 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
